Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Vendrame

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Diabetes Science and Technology|October 11, 2021
Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational StudyDaniel J DeSalvo, Nudrat Noor, Cicilyn Xie, et al.
Diabetes Technology & Therapeutics|April 14, 2021
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 PandemicJoyce M Lee, Emily Carlson, Anastasia Albanese-O'Neill, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2019
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective StudyViral N Shah, Stephanie N DuBose, Zoey Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2020
COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance StudyGrenye O'Malley, Osagie Ebekozien, Marisa Desimone, et al.
Pediatric Diabetes|December 12, 2013
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findingsAlberto Pugliese, Mingder Yang, Irina Kusmarteva, et al.
Diabetes|January 21, 2010
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cellsFrancesco Vendrame, Antonello Pileggi, Elsa Laughlin, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Diabetes Science and Technology|October 11, 2021
Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational StudyDaniel J DeSalvo, Nudrat Noor, Cicilyn Xie, et al.
Diabetes Technology & Therapeutics|April 14, 2021
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 PandemicJoyce M Lee, Emily Carlson, Anastasia Albanese-O'Neill, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2019
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective StudyViral N Shah, Stephanie N DuBose, Zoey Li, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2020
COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance StudyGrenye O'Malley, Osagie Ebekozien, Marisa Desimone, et al.
Pediatric Diabetes|December 12, 2013
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findingsAlberto Pugliese, Mingder Yang, Irina Kusmarteva, et al.
Diabetes|January 21, 2010
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cellsFrancesco Vendrame, Antonello Pileggi, Elsa Laughlin, et al.
JAMA|June 17, 2020
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical TrialRichard E Pratley, Lauren G Kanapka, Michael R Rickels, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Pageof 4